As of 2025-04-30, the Relative Valuation of Nova Mentis Life Science Corp (NOVA.CN) is (1.01) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 CAD, the upside of Nova Mentis Life Science Corp based on Relative Valuation is -2627.5%.
The range of the Relative Valuation is (0.99) - (1.04) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.9x - 24.1x | 23.0x |
| Forward P/E multiples | 20.2x - 23.1x | 21.6x |
| Fair Price | (0.99) - (1.04) | (1.01) |
| Upside | -2574.9% - -2710.8% | -2627.5% |
| Date | P/E |